• Profile
Close

Supplementation with dexmedetomidine for transsphenoidal resection of pituitary adenoma: A meta-analysis of randomized controlled trials

Clinical Neuropharmacology Jan 22, 2021

Liu Z, Gao C, Liu C, et al. - Researchers sought to determine the influence of dexmedetomidine supplementation on hemodynamic stability for transsphenoidal resection of pituitary adenoma via performing a systematic review and meta-analysis. Searching PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases, they identified four randomized controlled trials involving 160 patients as eligible for inclusion in the meta-analysis. Findings support the effectiveness of dexmedetomidine supplementation in improving hemodynamic stability for transsphenoidal resection of pituitary adenoma.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay